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ABSTRACT
Objective:  The development of a thoracoscopically
assisted technique to be performed with the patient
under local anesthesia for both diagnostic and therapeu-
tic purposes when treating pleural effusions and empye-
mas in high-risk surgical patients.
Methods: Twenty patients with pleural effusion or
empyema who were also determined to be at high risk
for complications following a thoracotomy, pleural biop-
sy, general anesthesia, or all of these, underwent place-
ment of a thoracoscope while under local anesthesia fol-
lowed by thoracic fluid drainage, pleural biopsy, and
pleurodesis as required. Patients were retrospectively
evaluated for a variety of factors including personal his-
tory, pre-existing medical conditions, and pre- and post-
operative course.
Results: The average age of the patients was 59 years
(18 to 89) with a 55% male/45% female sex distribution.
Patients had this procedure as a consequence of malig-
nancy (50%), empyema (30%), spontaneous pneumotho-
rax (10%), bronchiectasis (5%), or heart failure (5%). The
average duration of the procedure was 62 minutes (20 to
190), with an average of 861 mL of fluid drainage, and
114 mL of estimated blood loss. The tube thoracostomy
was usually removed on the sixth (0 to 13) postproce-
dure day. This procedure was well tolerated by the
patients with the majority of pain management being
achieved with patient controlled analgesia (58%). The
direct complication rate was 10%, with 2 patients requir-
ing endotracheal intubation.
Conclusion: This novel thoracoscopic procedure repre-
sents an acceptable alternative to the traditional treat-
ment of pleural effusions and empyema with comparable
outcome parameters and morbidity. This technique may
INTRODUCTION
Thoracoscopy, in an attempt to decrease the morbidity
associated with a thoracotomy, was first introduced into
clinical medicine by Jacobaeus in 1912.1 During the
ensuing decades, it was utilized extensively for the diag-
nosis of pleural disease, particularly in patients with sus-
pected tuberculosis.2 
Recently, with the advent of equipment allowing better
visualization and instrumentation, thoracoscopy is cur-
rently being utilized not only for diagnostic purposes but
also for therapeutic purposes. The benefits of this less
invasive technique are numerous, namely: (1) an
increase in both immediate and late postoperative
patient comfort, (2) less impairment of pulmonary func-
tion, (3) ability to obtain tissue for histologic and micro-
biologic analysis, (4) avoidance of large thoracotomy
incisions that impede adjuvant radiotherapy in the early
postoperative period, (5) a reduction in length of hospi-
tal stay as related to the procedure.3 
Approximately 40% of all pleural effusions are secondary
to malignancy, which accounts for nearly 100,000 cases
annually in the United States alone.4,5 Nearly half of the
patients with disseminated cancers eventually develop
pleural effusion.4,6 Malignant pleural effusions are most
commonly associated with lung carcinoma (17-56%);
breast carcinoma (15-38%); lymphoma, leukemia (6-
17%); ovarian carcinoma (7-16%); and gastrointestinal
malignancies usually in the stomach (3-6%).4,7-11
Furthermore, diagnostic and therapeutic interventions
related to pleural effusions represent a tremendous
source of morbidity and mortality in this setting. This
represents a diagnostic and therapeutic dilemma in these
high-risk surgical patients. Perhaps by the introduction of
thoracoscopically assisted pleural drainage, acquisition of
tissue specimens and pleurodesis with local anesthesia, a
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eventually become the standard of care for the treatment
of pleural effusions. 
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tremendous source of morbidity and mortality can be
reduced without affecting patient care. We compared in
our study the traditional technique of evaluating pleural
effusion (puncture thoracentesis, repeated chest tube
insertion, and bedside or operating room pleurodesis
blindly), with our direct visualization technique and
direct biopsy, but we are not comparing this technique in
our study with double lumen intubation with thoracoto-
my for evaluating the pleural cavity. 
METHODS 
Patient Selection
Twenty patients admitted to or consulted at the thoracic
surgical service of a large, urban, teaching hospital from
1996 to 1998, with the diagnosis of symptomatic pleural
effusions were included in the study. All had cardiopul-
monary complaints as a consequence of the pleural effu-
sions and required evaluation or diagnosis of the under-
lying medical problem that caused the pleural effusion.
This then necessitated the pleural fluid aspiration, pleural
biopsy, and pleurodesis.
A retrospective analysis was performed via a chart review
with respect to sex, race, underlying medical condition,
preoperative diagnosis, duration of procedure, amount of
pleural fluid drained, the time tube thoracostomy
remained in place, postoperative histologic diagnosis,
postoperative pain management, and complications. 
Equipment
The procedures were performed in a fully equipped
operating room. A rigid thoracoscope with cold light
source was used.12,13 The equipment required for rigid
thoracoscopy are trocars, telescopes, and forceps (Figure
1). Eleven-mm trocars, which are smaller than the com-
monly used trocars, with obturators and cannulas were
used because they were easier to introduce and less
painful to the patient. Operating telescopes with 30∞ side
view capability were coupled with television monitoring
and inserted through endoscopy ports for use in this
study. In this manner, we were able to view the entire
pleural surface of the thorax as well as a majority of the
thoracic contents after gentle retraction of the lung. 
Illuminated forceps are ideal for biopsies of the parietal
pleura, diaphragmatic pleura, and fibrous pleural lesions
under direct vision. This is made possible through the use
of 1 port with the aid of 5-mm coagulating forceps, again
introduced through the same port (Figure 2). 
Technique 
Previous experience with thoracoscopic procedures and
techniques are required in performing this procedure.
The patients were placed in the supine position, with the
head of the bed elevated as needed. The surgeon and the
Figure 1. Equipment: (1) suture material, (2) talcum powder, (3) 10-
mm trocar with obturator, (4) scalpel, (5) right-angle telescope (0
degree), (6) dissector with diathermy, (7) dissector with diathermy.
Figure 2. Thoracoscopy with video recorder: Complete evalua-
tion of the pleural cavity is possible. The lung is retracted for
parietal and visceral pleural biopsies. Lysis of adhesions and lung
biopsies could be easily illustrated on the video screen.assistant should be on the side of the effusion while per-
forming the procedure. 
Anesthesia with Lidocaine 1% (2 mg/kg) about 30 to 40
mL was given along with a single agent for sedation,
analgesia, and amnesia [Droperidol (5 mg), Pethidine (5
to 10 mg), Propofol (400 mg), and Fentanyl (5 mcg)]. The
patient was masked with 40% oxygen, and a simple
operating room protocol was followed including pulse,
blood pressure, and blood-gas saturation monitoring
(Figure 3). 
A needle thoracentesis with an 18-gauge needle was per-
formed to confirm the presence of the fluid before the
start of the procedure. The incision was usually along the
anterior axillary line between the fifth and sixth inter-
costal spaces. However, the choice of entry can vary
depending on the indication of thoracoscopy and the
location of the fluid. A small skin incision is made along
the axillary line followed by introduction of a 10-mm tro-
car with a cannula into the thoracic cavity. The pleural
fluid was aspirated and sent for cytologic, microbiologic,
and biochemical analysis. 
Next, the 30∞ side arm operating telescope was intro-
duced through the same port after the trocar was
removed. Almost complete visualization of parietal and
visceral pleura is possible after gentle retraction of the
lung. Blunt and sharp dissection can be easily performed
through the same port with a blunt probe, forceps, or
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electrocautery. Biopsies can be easily performed with
illuminated forceps introduced through the same port.
Bleeding after entry into the thorax or from the biopsy
site is possible but is easily controlled with diathermy
forceps. After completion of all biopsies, pleurodesis was
performed by introduction of 16g of sterilized asbestos
free, talcum powder. At the end of the procedure, a 36
Fr. right-angle tube thoracostomy was inserted and
secured in place. This was left in place until the fluid
drainage was less than 100 mL/day, the lung completely
expanded, and no evidence existed of an air leak. Chest
radiographs were obtained on a daily basis to assess the
position on the tube thoracostomy and progress of the
patient. The same standard of care was applied to all
patients; however, the variation in particular parts was
modified according to the underlying diagnosis and
pathology. 
RESULTS 
The average age of the patients was 59 years (18 to 89)
with a 55% male/45% female sex distribution. Sixty-five
percent were white and 30% were Hispanic.
The underlying pathologic diagnoses were malignancy
(50%), empyema (30%), spontaneous pneumothorax
(10%), bronchiectasis (10%) or heart failure (5%) (Table 1).
The patients had a variety of underlying medical prob-
lems including malignancies, whether primary or
metastatic, cardiac problems, infectious diseases, such as
tuberculosis, peripheral vascular diseases, and finally dia-
betes.
Figure 3. The patient is in the supine position, and the proce-
dure performed with the patient under local anesthesia without
intubation. 
Table 1.
Underlying Pathology of Pleural Biopsies
Diagnosis Percentage
Malignancy (primary and secondary) 50%
(10/20)
Empyema 30%
(6/20)
Hemothorax and Pneumothorax 10%
(2/20)
Bronchiectasis 5%
(1/20)
Other causes 5%
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The average duration of the procedure was 62 minutes
(20 to 190) with an average of 861 mL of fluid drainage
from the pleural cavity and 114 mL of estimated blood
loss during the procedure.
No patients required conversion to an open thoracotomy
or evaluation of the pleural space under general anesthe-
sia. Two patients (10%) required endotracheal intubation
in the early postoperative period due to underlying pul-
monary insufficiency.
The chest tube was usually removed on the sixth (0 to 13)
postprocedure day. The procedure was generally well
tolerated by the patients with the majority of pain man-
agement being achieved by patient-controlled analgesia
(58%)  (Table 2). The histological diagnosis confirmed
that malignancy was the main etiological factor in 60% of
the cases (Table 3). No postoperative mortality occurred,
and the morbidity rate was 10% due to 2 patients requir-
ing short-term postoperative intubation.
The longest follow-up was 12 months (2 to 26 months).
No long-term sequelae of the procedure occurred, and no
patient developed a recurrent pleural effusion. 
DISCUSSION
Minimal access surgery has become an accepted
approach for the diagnosis and treatment of many surgi-
cal diseases. Several distinct advantages of minimal
access surgery have been described in the literature in the
past few years.3 It is well known that thoracoscopy is a
procedure in the pleural cavity with 92% to 97% sensitiv-
ity and 99% specificity.8 Traditionally, patients with pleu-
ral effusion require multiple diagnostic and therapeutic
procedures including needle thoracentesis with cytologi-
cal and bacteriological evaluation, multiple blind pleural
biopsies, tube thoracostomy, and finally pleurodesis
using talcum powder or chemical substances. These pro-
cedures require multiple hospital admissions and their
associated costs. 
Evaluation of the pleural space under general anesthesia
with the double lumen endotracheal tube and possible
mini-thoracotomy especially in high-risk patients increas-
es the hospital mortality to approximately 10%.14
Repeated pleural fluid drainage and tube thoracostomy
are very painful procedures to the patient and require a
tremendous expenditure of resources with an unaccept-
ably high recurrence rate of 97% within 30 days.9 Tube
thoracostomy drainage alone is effective in only 22%.14
Our procedure is of short duration with an average time
of 62 minutes and can be easily performed by a trained
surgeon. Adequate visualization of the parietal and vis-
ceral pleura can be obtained by manipulating the thora-
coscope, and even lung biopsy with limited lung resec-
tion is possible. In 18 out of 20 patients, the procedure
was very successful and full visualization of the pleural
space was complete.
We emphasize the advantage of this procedure over the
traditional methods and over thoracotomy or thora-
Table 2. 
Pain Control in the Postoperative Period
Postoperative Pain Control Percentage
Patient control analgesia 55.0%
(11/20)
Duragesic patches and local anesthesia 25.0%
(5/20)
Opioid and Nonsteroidal anti- inflammatory 10.0%
drugs (NSIAD) (2/20)
Epidural anesthesia 10.0%
(2/20)
Table 3. 
Postoperative Histopathological Diagnosis
Histopathological Diagnosis Percentage
Metastatic carcinoma 20.0%
(4/20)
Primary lung squamous cell carcinoma 15.0%
(3/20)
Primary lung adenocarcinoma 15.0%
(3/20)
Lung oat cell carcinoma 5.0%
(1/20)
Mesothelioma 5.0%
(1/20)
Lung tuberculosis 5.0%
(1/20)
Infectious origin 15.0%
(3/20)
Nonspecific 20.0%
(4/20)coscopy with the patient under general anesthesia in all
areas of the thoracic cavity.15 It was found that a combi-
nation of pleural fluid cytological examination and pleu-
ral biopsy histological examination can provide a defini-
tive diagnosis in 73% to 90% of the cases; these results
are comparable to those of our study.14 It should be
noted that when a biopsy cannot be obtained, as with
tube thoracostomy drainage and pleurodesis, the cyto-
logical diagnosis rate is 67%, and the blind pleural biop-
sy accuracy rate is 58% to 71%.10,16,17 This procedure was
well tolerated by the patients, and postoperative pain
was relatively easily controlled when compared with
pain control in more traditional procedures. Our compli-
cation rate was acceptable (10%), and we had no case of
mortality related to this procedure; however, the pain
was easily controlled postoperatively in spite of the fact
that this procedure was performed with the patient under
local anesthesia. Further analgesia might be required
depending on the patient’s pain threshold. 
This technique may have some utility. However, if a
patient is deemed too frail for general anesthesia and has
a suspected malignancy, one could argue that perhaps
the procedure be performed with our technique or that
bedside pleurodesis be performed without the benefit of
tissue diagnosis.
In conclusion, this procedure can be easily performed
with the patient under local anesthesia, general or locu-
lated pleural effusions can be easily evaluated, pleural
biopsies can be obtained, and pleurodesis can be per-
formed all in a single procedure with low morbidity.
These characteristics make it useful in the evaluation of
high-risk patients forsaking the more traditional proce-
dures.
Currently, a prospective study evaluating this procedure
and the traditional multi-step technique with respect to
the criteria of patient participation, cost, hospital stay,
pain control, recurrence rate, and patient satisfaction, is
under development. 
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